Share Name Share Symbol Market Type Share ISIN Share Description
Ark Therapeutics Group LSE:AKT London Ordinary Share GB00BSZLMS59 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 63.25p 0.00p 0.00p - - - 0.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.1 0.5 126.5 132.37

ARK Therapeutics (AKT) Latest News

Real-Time news about Ark Ther Grp (London Stock Exchange): 0 recent articles
More ARK Therapeutics News
ARK Therapeutics Takeover Rumours

ARK Therapeutics (AKT) Share Charts

1 Year ARK Therapeutics Chart

1 Year ARK Therapeutics Chart

1 Month ARK Therapeutics Chart

1 Month ARK Therapeutics Chart

Intraday ARK Therapeutics Chart

Intraday ARK Therapeutics Chart

ARK Therapeutics (AKT) Discussions and Chat

ARK Therapeutics (AKT) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all ARK Therapeutics trades in real-time

ARK Therapeutics (AKT) Top Chat Posts

DateSubject
01/3/2015
16:36
hedgehog 100: EJ, The directors here do seem to be very good at looking after themselves. They allowed themselves to invest in the placing at 10.1p, a discount of over 80% to the suspended share price consolidation-adjusted. Normal retail shareholders did not have that opportunity. And after the first day of trading back from suspension on Friday, the share price is now at 28.5p. And it was announced late in Friday afternoon trading that they have granted two of themselves options at 10.1p: 27/02/2015 16:07 UKREG Ark Therapeutics Group PLC Board Changes and Directors' Dealings London, UK, 27 February 2015 (LSE: AKT): The Company announces that it has today issued options to subscribe for new ordinary shares of 10 pence each in its capital, including awards to the following Directors: Name Role Number of options Exercise price per share --------------- -------------------- ----------------------- --------------- Dominic Tonner Director (Chief 279,035 10.1 pence Executive Officer) --------------- -------------------- ----------------------- --------------- Daniel Smith Director (Chief 209,277 10.1 pence Financial Officer) --------------- -------------------- ----------------------- --------------- Each of the above options was granted pursuant to the 2014 Ark Therapeutics Group plc Enterprise Management Incentive Share Option Plan. As outlined in the Circular issued to Shareholders on 21 November 2014 (the "Circular") and the Prospectus published on 26 February 2015 (the "Prospectus"), the options were granted at an exercise price equal to the Subscription Price (as defined in the Circular and the Prospectus) of 10.1 pence, and will vest in full on the later of the first anniversary of the date of grant and the date that the market price of an ordinary share is at least twice the Subscription Price, and has been for a continuous period for 15 days. No consideration was paid for the grant of options. ... " http://uk.advfn.com/news/UKREG/2015/article/65662354
03/11/2014
12:05
ten bag man: Significant minority: From the WWW. "A minority is anything below 50% of a group. An insignificant minority will be a minority so small it doesn't really matter, while a significant minority will be something like 30% of a group. Clearly not the majority but big enough to be important for whatever purpose you're using it for." 30% sounds about right to me. My sums are based on this 30%(it could be higher or lower than 30%, time will no doubt tell)! If,(and it's a big if) this is in the ball park then here are some of my ideas. AKT shares stopped trading on March 28th 2014 @0.524p with a market cap of £1.2M Just for that value to stay the same of the first day of dealing the new company would have to have a market cap of around £4M Anything under £4M and old AKT shareholders will be making a loss (Based on the share price of 28th March 2014. So here we go. Market cap on first day of dealing. £4M break even. Then each extra Million pounds of market cap should I think give ARK shareholders and extra 30% on top of the £1.2M market cap on March 28th 2014. Thus: Each extra million of market cap gives AKT shareholders an extra £300,000 If the market cap on the first day of dealing was £14M AKT shareholders should be better off to the tune of £3M pounds. The share price would then be up 250%.
03/11/2014
08:39
ten bag man: AKT shares traded at 0.345P at the start of 2014. The directors paid ten times that amount for stock,so just to get their cash back they require a massive jump in the share price. (10 x) The only way to do that,(in my view)is to do an RTO. The RNS OF THE 28th of March 2014 tells shareholders the plan is to pick up a lump of the new companies shares in exchange for the FULL PREMIUM listing AKT has. That in itself is pointing to an instant gain for AKT shareholders. In effect part of the new company is to be given to us.!(if the RTO goes through) On top of this we will then be shareholders in the NEW company. That new company would have wanted to come to the London Stock Market for a reason.
01/5/2014
06:07
tara7: Cash of £800,000 plus VAT refund of £142,000 since the year end. As posted above cash = share price. AGM should be by June 30th as per the accounts. 4 weeks notice required of the meeting. The RTO also requires a GM that in my view would be on the same day( to keep costs down) That would put the next RTO update in around 4 -5 weeks time, with the vote 4 weeks later. Trading would then re start and the market for the first time can / will re price the companies shares.
25/3/2014
13:25
tara7: To use the tax loss new company HAS to be in the same field as ATK. That said, it's not just the tax loss that has value here. It has a full listing ( only 3 or so fully listed shells) on the main market. V 40 odd on AIM. AKT also has cash = today's share price.
23/3/2014
14:30
tara7: ARK: [code AKT] Best case scenario; RTO by a massive Biotech company that is in profit. ARK"S tax loss would be worth many times ARK"S share price. Market cap £1M today V £24M of value [20% of £120M]. Second best scenario: ARK is taken out for its tax loss by any company,[has to be a biotech]again worth many times todays share price. Third best scenario: A large unlisted company from any sector does an RTO into ARK [Tax loss could not be used] This would be worth the cash within ARK plus in my view 100% to 1,000% depending on the terms, new investors, and so on.[We have seen companies do 500% plus within hours in the last month or two after deals have been done. The fourth best scenario: no deal is done, and the company shuts shop and hands back all the cash;[as they have said they will do.] Cash should be £1.5M as of 31/12/13 less running costs of £150,000 for the six months up to 31/12/13.[could be a tad less if the company has not pulled in all the monies due, by that date] MARKET CAP TODAY £1.1M
19/3/2014
12:10
tara7: In todays D Mail.Lost 99.6% over the last 10 years.Cash should be above the share price in the accounts year ended 31/12/13.Those results have to be out by the end of next month.Directors talk of a deal/ RTO or they are going to hand back the cash to shareholders.
21/1/2013
15:40
binladin: oversold imo...........share price was 150p in 2007......there were a lot of drugs in the pipeline...and now 1,5p where is the common sense ???atleaset now they know what is possible and is not...they are in a better postion of producing something they can sell............all this takes time...the city has no patience...if they are goiing to produce something it is now ...the risk reward favours the investor imo.... directors could be buying as well...
21/1/2013
13:24
joeblogg2: Really don't know what agend the new BOD and how much do they need with the statement issued today: Shareholders should note that in all likelihood, given the current share price and the expected level of investment being discussed, any equity financing proposal will be materially dilutive and subject to shareholder approval. They have destroyed the share price in one swoop!!!
15/4/2011
11:18
duncandisorderly: Speaking of comedy Doc, how did you do on Regal?I made a nice 450k on them alone.Not bad for a few months work is it? I'm glad you're on here now as I can watch the share price deteriorate to nothing as you're the kiss of death to anything you invest in with your remaining £100. Why don't you lease a corner shop or some other business.You could double your money selling lemon flavoured Bon-bons,lol. How much did you lose again, lol.Brilliant!
ARK Therapeutics share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V: D:20161204 22:21:58